# Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)

> **NCT00813709** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 402 (actual)

## Conditions studied

- Multiple Sclerosis
- Clinically Isolated Syndrome

## Interventions

- **DRUG:** RNF
- **DRUG:** RNF
- **DRUG:** RNF
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00813709
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-08
- **Final completion:** 2013-09
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2017-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813709, "Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00813709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*